CRI's new website that seeks to engage, educate, and empower patients and their loved ones to learn more about cancer immunotherapy as a treatment option across numerous tumor types.
Cancer patients, donors, scientists, and other supporters all stand behind the Cancer Research Institute. Read their stories and learn about what motivates each of us to keep fighting against cancer.
Join us on June 25, 2016, for a one-day, multi-distance “Answer to Cancer” cycling event throughout New York's Lower Hudson Valley and sponsored by Bristol-Myers Squibb.
We gratefully accept donations made in memory or in honor of a loved one. Your gift will be acknowledged to whomever you specify.
Hosted by CRI, EATI, CIMT, and AACR, register today for "Translating Science into Survival," on September 25-28, 2016, in New York City.
Curious about the latest developments in cancer immunotherapy research? Listen in as leading scientists discuss immune-based treatments across numerous cancer types in our free "Cancer Immunotherapy and You" webinar series.
When the Cancer Research Institute was founded in 1953, we knew then that immune-based treatments would transform cancer medicine. In more than six decades since, we've made numerous groundbreaking discoveries that have given more patients new hope today.
Here you can browse press releases from the Cancer Research Institute. These include important announcements, program accomplishments, partnership news, special event reports, and more.
Use the drop down filter to browse by year.
June 1, 2016
May 12, 2016
April 11, 2016
April 6, 2016
Cancer Research Institute
Phone: (212) 688-7515 x242
Fax: (212) 832-9376
'AnswerToCancer' website provides insight into new immune system cancer treatment, Kathryn Carse
"Cancers don't operate the way most diseases do. Instead of invading from outside, they arise from mutations in the body's own cells, making it difficult for the immune system to recognize cancer as foreign."
– Jill O'Donnell-Tormey, Ph.D., CRI CEO and director of scientific affairs
June 4, 2014
Immune Design, NY Non-Profits Team Up To Boost Cancer Drugs, Ben Fidler
“These are things as a small private company we would not have been able to afford. [It] allows companies like ours that don’t have all the tools together to have our tools being tested in combination with other companies’ tools.”
– Carlos Paya, Immune Design CEO
June 12, 2013
Cancer Has a “Game-changing” Moment, Mary Elizabeth Williams
“We always believed these therapies could have this type of impact…We’re an organization that’s been doing this for 60 years, and we’re in a very different space in this field now. It doesn’t work for everybody, but we are seeing remarkable responses. It tells you the potential. This is a game-changing time.”
– Jill O’Donnell-Tormey, Ph.D., CRI CEO and director of scientific affairs
December 11, 2012
The T-cell Army, Jerome Groopman
"You are not treating the cancer—you are treating the immune system. And it was the first drug of any type to show a survival benefit in advanced-melanoma patients in a randomized trial.”'
– James P. Allison, Ph.D., director of CRI Scientific Advisory Council
April 23, 2012